Emilie D Henry, MD
Disclosures: Nothing to disclose - 04/10/2017

 

Emilie Henry, MD is the Pediatric Cardiac ICU Medical Director at Children’s Hospital in Oklahoma City and Associate Professor of Pediatrics in Pediatric Critical Care at the University of Oklahoma. She has served as the Pediatric Cardiac ICU Medical Director since 2019 and has focused on quality improvement in the CICU as well as processes, education and expansion of the overall CICU team including discharge coordinator, dedicated Cardiac Educator, and a dedicated Cardiac CNS. Dr. Henry, along with the nursing and surgical leadership, have overseen the CICU renovation that began in 2019 and will complete its expansion from a 12 bed unit to a 25 bed unit in 2022. She is the site PI for an NIH funded study called PROSPect, looking at the best management for children intubated for pediatric ARDS. Additionally, she has been involved with pharmacokinetic studies surrounding fentanyl and bumetanide, common drugs used in the CICU.  She has been involved with hospital wide quality research regarding unplanned extubations and CLABSIs and is an active participant on the University of Oklahoma IRB.  She has co-authored two textbook chapters on ECMO from Comprehensive Critical Care and has been involved with nursing, resident, advanced practice provider, and fellow education in pediatrics and pediatric critical care since 2007.

 

1.

Lim, S. y., Henry, E. D.#, Johnson, P.# (2021). Analysis of Fentanyl Pharmacokinetics, and its Sedative Effects and Tolerance in Critically-Ill Children. Pharmacotherapy. PMID: 33604895.

2.

Lim, S., Woo, S.#, Jamie, M.#, Skrepnek, G.#, Henry, E. D., Johnson, P.# (2019). Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Non-obese Children. Pediatric Critical Care Medicine, Dec 2019(12), e556-e564. PMID: 31568259.

3.

Lim, S., Jamie, M., Henry, E. D., Johnson, P. (2018). Dosing For Fentanyl Infusion in Obese Children: Just Because it is What We have Always Done Doesn't Mean it's Right. Journal Pediatric Pharmacology, May-Jun 2018(3), 223-226. PMID: 29970980. DOI: 10.5863/1551-6776-23.3.223

4.

Ibach, B., Henry, E. D., Johnson, P. (2016). Acute Kidney Injury in a Child Receiving Vancomycin and Piperacillin/Tazobactam. J Pediatr Pharmacol Ther 2016, 21(2), 169-175. PMID: 27199625.

5.

Allen, C., Welliver, R. C.#, Fogarty, M.#, Henry, E. D. (2016). Intravenous Immunoglobulin Therapy for Cerebral Vasculitis Associated with Rocky Mountain Spotted Fever. J Pediatr Intensive Care 2016, 3. DOI: http://dx.doi.org/ 10.1055/s-0036-1587327.

6.

Abramson, E. L., Naifeh, M. M., Stevenson, M. D., Todd, C., Henry, E. D., Chiu, Y.-L., Gerber, L. M., Li, S.-T. T. (2014). Research Training Among Pediatric Residency Programs: A National Assessment. Academic Medicine, 89(12), 1674-1680. DOI: 10.1097/acm.0000000000000404

7.

Bulkley, C. F., Johnson, P. N., Henry, E. D., Harrison, D., Lewis, T. V., Miller, J. L. (2012). Bumetanide continuous-infusion dosing in critically ill pediatric patients. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 69(17), 1458, 1460-1. PMID: 22899737. DOI: 10.2146/ajhp120056

Book Chapters

1.

Cunnyngham, C. B., Henry, E. D.# (2016). Extracorporeal Membrane Oxygenation, Ch 88. Comprehensive Critical Care: Pediatric (2nd ed., pp. 949-957). Mount Prospect, IL: Society Critical Care Medicine.

2.

Cunnyngham, C., Henry, E. D. (2012). Extracorporeal Membrane Oxygenation, Chapter 100. Comprehensive Critical Care: Pediatric (2nd ed., pp. 1359). Mount Prospect, IL: Society of Critical Care Medicine.

Other

1.

Lee, A. E. (in press). Development of an ECLS Expert Physician Team in the Pediatric Intensive Care Unit. In Gormley, A. K., Henry, E. D. (Eds.), Conference Abstract-ELSO 31st Annual Meeting (virtual).. American Society for Artificial Internal Organs.

 

 

 

 

 

Updated 10/13/21